GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Net Issuance of Preferred Stock

AP Biosciences (ROCO:6945) Net Issuance of Preferred Stock : NT$0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

AP Biosciences's net issuance of preferred for the six months ended in Jun. 2024 was NT$0.00 Mil. The number is 0, which means that AP Biosciences has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

AP Biosciences's net issuance of preferred for the trailing twelve months (TTM) ended in Jun. 2024 was NT$0.00 Mil.

AP Biosciences Net Issuance of Preferred Stock Historical Data

The historical data trend for AP Biosciences's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Net Issuance of Preferred Stock Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Net Issuance of Preferred Stock
- - - -

AP Biosciences Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Net Issuance of Preferred Stock Get a 7-Day Free Trial - - - - -

AP Biosciences Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AP Biosciences Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

AP Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Net Issuance of Preferred Stock
Comparable Companies
ROCO:6461 ROCO:6704 ROCO:4169 ROCO:6926 ROCO:4911 ROCO:4168 ROCO:1777 ROCO:4130 ROCO:4194 ROCO:6733 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
Website
https://www.apbioinc.com
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences Headlines

No Headlines